JP2023510109A5 - - Google Patents

Info

Publication number
JP2023510109A5
JP2023510109A5 JP2022537683A JP2022537683A JP2023510109A5 JP 2023510109 A5 JP2023510109 A5 JP 2023510109A5 JP 2022537683 A JP2022537683 A JP 2022537683A JP 2022537683 A JP2022537683 A JP 2022537683A JP 2023510109 A5 JP2023510109 A5 JP 2023510109A5
Authority
JP
Japan
Prior art keywords
formula
compound
salt
preparing
converting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022537683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023510109A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/065666 external-priority patent/WO2021127214A1/en
Publication of JP2023510109A publication Critical patent/JP2023510109A/ja
Publication of JP2023510109A5 publication Critical patent/JP2023510109A5/ja
Priority to JP2025193971A priority Critical patent/JP2026016830A/ja
Pending legal-status Critical Current

Links

JP2022537683A 2019-12-20 2020-12-17 合成プロセス及び中間体 Pending JP2023510109A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025193971A JP2026016830A (ja) 2019-12-20 2025-11-13 合成プロセス及び中間体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962951836P 2019-12-20 2019-12-20
US62/951,836 2019-12-20
PCT/US2020/065666 WO2021127214A1 (en) 2019-12-20 2020-12-17 Synthetic processes and intermediates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025193971A Division JP2026016830A (ja) 2019-12-20 2025-11-13 合成プロセス及び中間体

Publications (2)

Publication Number Publication Date
JP2023510109A JP2023510109A (ja) 2023-03-13
JP2023510109A5 true JP2023510109A5 (https=) 2023-12-25

Family

ID=76478539

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022537683A Pending JP2023510109A (ja) 2019-12-20 2020-12-17 合成プロセス及び中間体
JP2025193971A Pending JP2026016830A (ja) 2019-12-20 2025-11-13 合成プロセス及び中間体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025193971A Pending JP2026016830A (ja) 2019-12-20 2025-11-13 合成プロセス及び中間体

Country Status (14)

Country Link
US (1) US20230113948A1 (https=)
EP (1) EP4077473A4 (https=)
JP (2) JP2023510109A (https=)
KR (1) KR20220119052A (https=)
CN (1) CN114846051A (https=)
AU (1) AU2020408039A1 (https=)
BR (1) BR112022012226A2 (https=)
CA (1) CA3165101A1 (https=)
IL (1) IL294064A (https=)
MX (1) MX2022007738A (https=)
NZ (1) NZ790488A (https=)
PH (1) PH12022551512A1 (https=)
TW (1) TW202136227A (https=)
WO (1) WO2021127214A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3020585A1 (en) * 2016-04-11 2017-10-19 Arbutus Biopharma Corporation Targeted nucleic acid conjugate compositions
CN118591552A (zh) * 2022-01-30 2024-09-03 成都凌泰氪生物技术有限公司 一种配体、其制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5923998A (en) 1997-01-31 1998-08-25 Avid Therapeutics Inc. 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
GB0505969D0 (en) * 2005-03-23 2005-04-27 Novartis Ag Organic compounds
US8921381B2 (en) 2010-10-04 2014-12-30 Baruch S. Blumberg Institute Inhibitors of secretion of hepatitis B virus antigens
WO2013058824A1 (en) * 2011-04-07 2013-04-25 Cornell University Monomers capable of dimerizing in an aqueous solution, and methods of using same
JP5977347B2 (ja) 2011-07-01 2016-08-24 バルーク エス．ブルームバーグ インスティテュート Ｈｂｖ感染に対する抗ウイルス剤としてのスルファモイルベンズアミド誘導体
ES2575398T3 (es) 2012-03-31 2016-06-28 F. Hoffmann-La Roche Ag 4-Metil-dihidropirimidinas novedosas para el tratamiento y la profilaxis de la infección por el virus de la hepatitis B
WO2014089296A2 (en) 2012-12-06 2014-06-12 Institute For Hepatitis And Virus Research Functionalized benzamide derivatives as antiviral agents against hbv infection
BR112015015584A2 (pt) 2012-12-27 2017-12-12 Baruch S Blumberg Inst novos agentes antivirais contra infecção por hbv
CA3020585A1 (en) * 2016-04-11 2017-10-19 Arbutus Biopharma Corporation Targeted nucleic acid conjugate compositions
MX2019012280A (es) * 2017-04-11 2020-01-23 Arbutus Biopharma Corp Composiciones dirigidas.
WO2019051257A2 (en) * 2017-09-11 2019-03-14 Arbutus Biopharma Corporation METHODS OF TREATING HEPATITIS B TYPE INFECTIONS
EP3873530A4 (en) * 2018-11-02 2022-11-09 Genevant Sciences GmbH THERAPEUTIC PROCESSES

Similar Documents

Publication Publication Date Title
JP7536721B2 (ja) キナーゼを修飾する１ｈ－ピロロ［２，３－ｂ］ピリジン誘導体の合成
WO2020111238A1 (ja) ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
JP2023510109A5 (https=)
JP2026016830A (ja) 合成プロセス及び中間体
JP7278775B2 (ja) 長鎖化合物の製造方法
JP3677790B2 (ja) ヌクレオシド誘導体とその製造方法
TWI896809B (zh) 4-硼-l-苯基丙胺酸及其中間體之製造方法
JP2006512364A5 (https=)
TW201028384A (en) Stereoselective synthesis of piperidine derivatives
JPWO1995001323A1 (ja) 光学活性アミノアルコール誘導体及びその製法
JP2011512336A5 (https=)
BG64597B1 (bg) Метод за синтез на хлоропуринови междинни съединения
WO2012146085A1 (zh) 用于合成前列腺素类药物的中间体及其制备方法
JP3657118B2 (ja) テアニンの製造方法
JP4934292B2 (ja) ５−アミノレブリン酸エステルリン酸類塩、その製造方法及びその用途
CN106083856A (zh) 一种可用于肿瘤治疗的嘌呤类丙氨酸衍生物及其制备方法和应用
CN1110479C (zh) 1－氯羰基－4－哌啶子基哌啶或其盐酸盐的生产方法
JP2771257B2 (ja) イミダゾール誘導体の製法
JP5399410B2 (ja) 免疫アジュバントｅ６０２０への合成前駆体のベータ−ケトアミド合成のための試薬および方法
JP2010526061A (ja) アミンおよびアミンオキシドで開始するアルキルホスフィン酸の合成方法
CN111233857B (zh) 一种连续化生产培西达替尼的合成方法
JP2020536870A5 (https=)
RU2450011C1 (ru) Способ получения n-пиразиноил-l-фенилаланил-l-лейцинбороновой кислоты или ее ангидрида
CN1383430A (zh) 胞苷衍生物的生产方法
JP2008526908A (ja) 有用な二置換アミンの新規な一段合成法